The current knowledge with regard to GSK3β in lung cancer progression is based on the clinical observation that phosphorylated GSK3β (Ser 9, kinase dead) might be a good prognostic marker for the epidermal growth factor receptor (EGFR) overexpressing lung carcinoma [6]. The gene discussed is GSK3B; the disease is lung carcinoma.